These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 36225196

  • 1. Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction.
    Ma RJ, Zheng QM, Zhang N, Sun ZG.
    Dis Markers; 2022; 2022():9311684. PubMed ID: 36225196
    [Abstract] [Full Text] [Related]

  • 2. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients.
    Hu K, Zheng QM, Wang YP, Zhao MM, Sun ZG.
    Eur J Cancer Prev; 2023 Mar 01; 32(2):119-125. PubMed ID: 36484275
    [Abstract] [Full Text] [Related]

  • 3. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H, Chen C, Yue J, Ma M, Ma Z, Yu Z.
    Zhonghua Zhong Liu Za Zhi; 2014 Feb 01; 36(2):141-6. PubMed ID: 24796465
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May 01; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.
    Ann Surg Oncol; 2012 Feb 25; 19(2):677-83. PubMed ID: 21822549
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
    Sun L, Chen F, Shi W, Qi L, Zhao Z, Zhang J.
    Diagn Pathol; 2014 Jul 16; 9():125. PubMed ID: 25029906
    [Abstract] [Full Text] [Related]

  • 8. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study.
    Chen L, Tang K, Wang S, Chen D, Ding K.
    Cancer Control; 2021 Jul 16; 28():10732748211026668. PubMed ID: 34155922
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction.
    Cao J, Yang T, Wang G, Zhang H, You Y, Chen J, Yang J, Yang W.
    Surg Oncol; 2018 Sep 16; 27(3):556-562. PubMed ID: 30217319
    [Abstract] [Full Text] [Related]

  • 10. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
    Reynolds JV, Ravi N, Muldoon C, Larkin JO, Rowley S, O'Byrne K, Hollywood D, O'Toole D.
    World J Surg; 2010 Dec 16; 34(12):2821-9. PubMed ID: 20827475
    [Abstract] [Full Text] [Related]

  • 11. Prognostic and Clinicopathological Significance of Lymph Node Metastasis in the Esophagogastric Junction Adenocarcinoma.
    Urakawa N, Kanaji S, Suzuki S, Sawada R, Harada H, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y.
    Anticancer Res; 2022 Feb 16; 42(2):1051-1057. PubMed ID: 35093906
    [Abstract] [Full Text] [Related]

  • 12. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
    Xu H, Zhang L, Miao J, Liu S, Liu H, Jia T, Zhang Q.
    World J Surg Oncol; 2020 Jun 27; 18(1):144. PubMed ID: 32593312
    [Abstract] [Full Text] [Related]

  • 13. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y, Liu D, Zeng D, Chen C.
    J Gastrointest Cancer; 2021 Sep 27; 52(3):983-992. PubMed ID: 32954465
    [Abstract] [Full Text] [Related]

  • 14. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 15. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S, Watanabe M, Kumagai K, Okamura A, Yuda M, Hayami M, Yamashita K, Imamura Y, Ishizuka N.
    Dis Esophagus; 2019 Dec 30; 32(11):. PubMed ID: 30791046
    [Abstract] [Full Text] [Related]

  • 16. Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
    Kamiya H, Komatsu S, Nishibeppu K, Ohashi T, Konishi H, Shiozaki A, Kubota T, Fujiwara H, Okamoto K, Otsuji E.
    BMC Cancer; 2023 Mar 08; 23(1):218. PubMed ID: 36890486
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.
    Feng Y, Jiang Y, Zhao Q, Liu J, Zhang H, Chen Q.
    BMC Surg; 2020 Nov 30; 20(1):302. PubMed ID: 33256690
    [Abstract] [Full Text] [Related]

  • 18. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB, Lin MQ, Li P, Xie JW, Lin JX, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM.
    Eur J Surg Oncol; 2017 Dec 30; 43(12):2333-2340. PubMed ID: 28928013
    [Abstract] [Full Text] [Related]

  • 19. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.
    Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, Rüdiger Siewert J.
    Cancer; 2000 Nov 01; 89(9):1874-82. PubMed ID: 11064343
    [Abstract] [Full Text] [Related]

  • 20. HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma.
    Wang ZY, Xiao W, Jiang YZ, Dong W, Zhang XW, Zhang L.
    Thorac Cancer; 2021 Mar 01; 12(5):650-658. PubMed ID: 33471419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.